Changeflow GovPing Pharma & Drug Safety AVID Medical Urgent Recall: Angiographic Syring...
Urgent Enforcement Amended Final

AVID Medical Urgent Recall: Angiographic Syringes in Convenience Kits

Favicon for www.fda.gov FDA Medical Device Recalls
Filed
Detected
Email

Summary

FDA CDRH issued an Early Alert notifying the public that AVID Medical initiated an urgent medical device recall for convenience kits containing angiographic syringes affected by Medline's Namic RA Syringes recall. The recall involves 11 tray configurations with specific model numbers and UDI-DIs. Affected customers must identify, quarantine, and add warning labels to affected kits, with direction to remove and destroy Namic RA Syringes due to risk of serious injury or death.

What changed

AVID Medical issued an urgent recall notification for convenience kits containing angiographic syringes affected by Medline's Namic Angiographic Control Syringes recall. The syringe rotating adaptor on affected devices may pose serious safety risks. Affected products span 11 tray configurations including CARDIAC CATH PACK, SAMMC ANGIOGRAPHY, HEART CATH, VA DETROIT CATH LAB PACK, CATH LAB, CARDIAC CATH TRAY, PERC TRAY, and NEURO IR PERIPHERAL kits.

Healthcare providers and facilities with affected kits on hand must immediately segregate and quarantine products, apply warning labels, and remove/destroy Namic RA Syringes. If use is unavoidable to prevent patient harm, extreme caution including manual stabilization of syringe-to-manifold connections and 100% continuous monitoring during procedures is required. Distributors who resold or transferred affected products must notify customers of this recall.

What to do next

  1. Identify and quarantine all affected convenience kits containing Namic RA syringes
  2. Apply warning labels to affected kits using AVID's labeling template
  3. Remove and destroy all Namic RA Syringes from affected kits

Penalties

Risk of serious injury or death if affected syringes are used without proper precautions

Archived snapshot

Apr 10, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.


CDRH is issuing this Early Alert **to notify the public of a potentially high-risk device issue.* The FDA will keep the public informed and update this web page as significant new information becomes available.*

Affected Product

The FDA is aware that AVID Medical has issued an Urgent Medical Device Recall Notification to affected customers recommending certain angiographic syringes included in convenience kits be removed from where they are used or sold. Affected devices:

Description (Tray Name) Model/Item Number UDI-DI
CARDIAC CATH PACK EAMC1000-05 10809160377314
SAMMC ANGIOGRAPHY SAMM066-15 10809160388495
HEART CATH, SELF REGIONAL SELF131-05 10809160408650
VA DETROIT CATH LAB PACK VMCD029 10809160388969
CATH LAB SACL75AM 20809160481377
CARDIAC CATH TRAY SHANDS JAX SHND401-04 10809160395615
CARDIAC CATH PACK WAFB208-02 10809160424759
PERC TRAY SLPC34-01 10809160511213
CARDIAC CATH PACK SAN23CARDQ DRCC36 10809160469088
NEURO IR PERIPHERAL (PS 64405) UINR44-01 20809160454439
CATH LAB SACL75-01 20809160481377

Full List of Affected Lots

What to Do

Identify kits with affected syringes. Apply over-labels to all affected kits on hand stating that the affected syringes must be removed and discarded from further use.

On March 13, AVID Medical sent all affected customers a letter recommending the following actions:

  • Identify, segregate, and quarantine all affected product.
  • Add warning labels to all affected kits stating that the affected syringes must be removed and discarded from further use.
    • Use the labeling template provided by AVID to print labels. This label should be applied in a prominently visible location to end-users. The location chosen should not cover any other critical product information found on existing product labeling.
  • If you are a distributor or have resold or transferred this product, notify them of this recall communication.
  • Per Medline, due to the risk of serious injury or death, customers are directed to remove and destroy all Namic RA Syringes. If use is unavoidable because failure to proceed would result in patient harm, the Namic RA syringe must be used with extreme caution and vigilance, including manual stabilization of syringe-to-manifold connections and continuous, 100% monitoring during setup and throughout the entire procedure.
  • All usage guidelines and the Instructions for Use are provided in Medline’s recall letter. Strict adherence to all usage guidelines and the Instructions for Use are required. Check this web page for updates. The FDA is currently reviewing information about this potentially high-risk device issue and will keep the public informed as significant new information becomes available.

Reason for Alert

AVID Medical initiated an urgent Medical Device Recall notification for convenience kits that contain syringes affected by Medline’s Namic Angiographic Control Syringes with Rotating Adaptor (“Namic RA Syringes”) recall.

Medline Industries stated that the syringe rotating adaptor on affected devices may unwind during use, resulting in a loose connection or full disconnection between the syringe and manifold. If unwinding occurs, there is potential for biohazard exposure, blood loss, and infection. Loose connections or disconnections may introduce air into the line, which could result in air embolism. These conditions may lead to serious injury or death. All units have the potential to exhibit this failure mode.

As of March 13, Medline Industries has reported four serious injuries and no deaths associated with this issue.

Device Use

Convenience kits contain various surgical instruments, dressings and/or other materials, and pharmaceutical components that are intended to be used during various surgical procedures.

Contact Information

Customers in the U.S. with adverse reactions, quality problems, or questions about this issue should contact AVID Medical at complaints@owens-minor.com.

Additional FDA Resources

Unique Device Identifier (UDI)

The unique device identifier (UDI) helps identify individual medical devices sold in the United States from distribution to use. The UDI allows for more accurate reporting, reviewing, and analyzing of adverse event reports so that devices can be identified more quickly, and as a result, problems potentially resolved more quickly.

How do I report a problem?

Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program.

  • ## Content current as of:

04/10/2026

-

Get daily alerts for FDA Medical Device Recalls

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Filed
March 13th, 2025
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Healthcare providers Medical device makers Distributors
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical device recall response Product quarantine and labeling Healthcare supply chain notification
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Product Safety Healthcare

Get alerts for this source

We'll email you when FDA Medical Device Recalls publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!